Guoqing Cao, PhD

CEO
Minghui Pharmaceutical
Shanghai, China (People's Republic)

Guoqing Cao, Phd, CEO, Founder/Chairman/CEO at Minghui Pharmaceutical
Bachelor of Biochemistry from Fudan University (1987)
PhD of Biochemistry from The Ohio State University, US (1995)
Postdoc fellow of Nobel Laureates Dr. Michael Brown, Dr. Joe Goldstein and Dr. Helen Hobbs at University of Texas, Southwestern Medical Center at Dallas (UTSW, 1995-1999)
Cardiometabolic discovery scientist and management at Eli Lilly & Company (1999-2011). Two programs finished phase 3 and phase 2 respectively.
Jiangsu Hengrui Medicine, Vice President of discovery/preclinical development/translational medicine/business development/portfolio management (2012-2017)
Minghui Pharmaceutical, Chairman and CEO. Discovery and development of small and antibody molecules for a variety of diseases. (2018-present)
More than 80 papers published in peer-reviewed journals and more than 50 patents/patent applications.

Disclosure information not submitted.

Presentation(s):

• ORF49-08 - Subcutaneous MHB018A, a N Ovel Anti- IGF-1R VHH Antibody, for Thyroid Eye Disease (TED): Results from a Phase 1/2 Study in Patients with Active and Chronic TED

  Monday, June 15, 2026
  3:00 PM - 3:15 PM CT